Shapsis Personalized prescription and dosing plan Weekly injections to control appetite and support steady weight loss Ongoing progress monitoring and nutritional support In-office or telemedicine appointments for flexible patient care Medications are dispensed only through FDA-regulated U.S
LC-MS, Liquid Chromatography-Mass Spectrometry
Most users notice improvements in endurance and recovery within 1 to 2 weeks of consistent use
Whether you are at home or 30,000 feet in the air, we are here to support your metabolic health with science and empathy
According to British Society for Haematology (BSH) guidelines and NICE Clinical Knowledge Summaries (CKS), the primary beneficiaries include: Key patient groups who may require B12 injections include: Pernicious anaemia patients requiring lifelong hydroxocobalamin 1mg intramuscularly every 23 months following initial loading doses Patients with gastrointestinal disorders including those who have undergone gastrectomy or ileal resection, and patients with conditions affecting B12 absorption such as Crohn's disease or coeliac disease Strict vegans and vegetarians though oral supplementation is usually sufficient unless malabsorption is present Elderly patients who may have reduced gastric acid production affecting B12 absorption Patients taking certain medications including metformin (MHRA advises monitoring B12 levels in long-term users, particularly those with risk factors or symptoms), proton pump inhibitors, and H2-receptor antagonists long-term [6] Individuals with neurological symptoms such as paraesthesia, ataxia, or cognitive impairment related to B12 deficiency Pregnant women with confirmed deficiency (hydroxocobalamin for malabsorption
